# Boehringer Ingelheim Pharma Gmbh & Co Kg – FDA Inspection, Apr 5, 2019

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/dbf348fc-bd1b-46d8-8ac0-0e7e2889aa61
Source feed: FDA_Inspections

> FDA inspection 1086418 of Boehringer Ingelheim Pharma Gmbh & Co Kg, April 05, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086418
- Company Name: Boehringer Ingelheim Pharma Gmbh & Co Kg
- Inspection Date: 2019-04-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1208927 - 2022-07-22
- [FDA Inspection 1102691 - 2019-09-19](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/db6a02f0-3ebc-4c6a-b689-a50299bdaa08)
- FDA Inspection 1107587 - 2019-08-15
- FDA Inspection 1072835 - 2018-10-19
- [FDA Inspection 1069908 - 2018-09-21](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/03de647a-2e62-474d-97a1-988dcb0acf6b)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/doan-n-singh/e52cfbca-5710-4765-8c5e-d534946b648d)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/5b2ffd33-30ee-4e73-bb66-fa96b4549154

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
